+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Hypoxia-induced gene expression in human macrophages: implications for ischemic tissues and hypoxia-regulated gene therapy



Hypoxia-induced gene expression in human macrophages: implications for ischemic tissues and hypoxia-regulated gene therapy



American Journal of Pathology 163(4): 1233-1243



Macrophages accumulate in ischemic areas of such pathological tissues as solid tumors, atherosclerotic plaques and arthritic joints. Studies have suggested that hypoxia alters the phenotype of macrophages in a way that promotes these lesions. However, the genes up-regulated by macrophages in such hypoxic tissues are poorly characterized. Here, we have used cDNA array hybridization to investigate the effects of hypoxia on the mRNAs of 1185 genes in primary human monocyte-derived macrophages. As shown previously in other cell types, mRNA levels for vascular endothelial growth factor (VEGF) and glucose transporter 1 (GLUT-1) were up-regulated by hypoxia. However, the mRNAs of other genes were also up-regulated including matrix metalloproteinase-7 (MMP-7), neuromedin B receptor, and the DNA-binding protein inhibitor, Id2. The promoters of GLUT-1 and MMP-7 confer hypoxic inducibility on a reporter gene in RAW 264.7 macrophages, indicating that the hypoxic up-regulation of these mRNAs may occur, at least in part, at the transcriptional level. GLUT-1 and MMP-7 mRNA were also shown to be up-regulated in hypoxic macrophages in vitro by real-time RT-PCR, and these proteins were elevated in hypoxic macrophages in vitro and in hypoxic areas of human breast tumors. The hypoxia up-regulated genes identified could be important for the survival and functioning of macrophages in hypoxic diseased tissues, and their promoters could prove useful in macrophage-delivered gene therapy.

(PDF emailed within 0-6 h: $19.90)

Accession: 010776012

Download citation: RISBibTeXText

PMID: 14507633

DOI: 10.1016/s0002-9440(10)63483-9


Related references

Hypoxia-induced changes in gene expression in human macrophages Implications for their role in ischemic diseased tissues and hypoxia-targeted gene therapies. Proceedings of the American Association for Cancer Research Annual Meeting 43: 1022, 2002

Expression of HIF-1alpha by human macrophages: implications for the use of macrophages in hypoxia-regulated cancer gene therapy. Journal of Pathology 196(2): 204-212, 2002

Understanding hypoxia-induced gene expression in early development: in vitro and in vivo analysis of hypoxia-inducible factor 1-regulated zebra fish insulin-like growth factor binding protein 1 gene expression. Molecular and Cellular Biology 26(3): 1142-1155, 2006

Noninvasive molecular imaging of hypoxia in human xenografts: comparing hypoxia-induced gene expression with endogenous and exogenous hypoxia markers. Cancer Research 68(20): 8597-8606, 2008

Augmentation of erythropoietin enhancer-mediated hypoxia-inducible gene expression by co-transfection of a plasmid encoding hypoxia-inducible factor 1alpha for ischemic tissue targeting gene therapy. Journal of Drug Targeting 16(1): 43-50, 2008

Over-expression of a hypoxia-regulated DT-diaphorase gene protects cardiac myocytes from hypoxia-reoxygenation induced apoptosis. Circulation 102(18 Supplement): II 84-II 85, October 31, 2000

Hypoxia-induced decoy receptor 2 gene expression is regulated via a hypoxia-inducible factor 1alpha-mediated mechanism. Biochemical and Biophysical Research Communications 391(2): 1274-1279, 2010

Gene therapy targeting for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by a hypoxia-inducible enhancer linked to a human alpha-fetoprotein promoter. Cancer Research 61(7): 3016-3021, 2001

Gene therapy targeting for hepatocellular carcinoma Selective and enhanced suicide gene expression regulated by hypoxia responsive element linked to human alpha-fetoprotein promoter. Hepatology 32(4 Pt 2): 179A, 2000

Hypoxia induces CD105 gene expression in human vascular endothelial cells Implications for hypoxia-initiated angiogenesis. Proceedings of the American Association for Cancer Research Annual Meeting 43: 27, 2002

A novel method for targeted gene therapy in ischemic tissues through viral transfection of an expression cassette containing multiple repetitions of hypoxia response element. Plastic and Reconstructive Surgery 123(2 Suppl): 76s-82s, 2009

Use of hypoxia-regulated gene expression in tumor-specific gene therapy. Current Opinion in Investigational Drugs 2(6): 839-843, 2001

Hypoxia-specific gene expression for ischemic disease gene therapy. Advanced Drug Delivery Reviews 61(7-8): 614-622, 2009

Regulatory systems for hypoxia-inducible gene expression in ischemic heart disease gene therapy. Advanced Drug Delivery Reviews 63(8): 678-687, 2011

HIF-3a2, one of the splicing variants of human hypoxia-inducible factor-3a, functions as an inhibitor of hypoxia-induced gene expression and tumor growth. The Journal of Urology 179(4): 88, 2008